Treatment of myelodysplastic syndromes with 5q deletion before the lenalidomide era; the GFM experience with EPO and thalidomide.

Source:http://linkedlifedata.com/resource/pubmed/id/18191202

Download in:

View as

General Info

PMID
18191202